Scientists have determined a method by which it is possible to predict human Alzheimer's disease long before its start. It will be sufficient to conduct a simple blood test.
Researchers from the Institute of Psychiatry at King's College London have found that high blood levels of a protein clusterin associated with the development of Alzheimer . This discovery may be in the next five years lead to the creation of a new diagnostic technique that allows an incurable neurological disease can distinguish many years before its occurrence.
Alzheimer's disease It is the most common form of dementia, of which currently affects about 35 million people across the earth. Scientists have for many decades persistently trying to find a treatment for this disease, but so far no any really effective drugs has been established.
Existing medicines can at any time to reduce the symptoms, but patients still eventually lose memory, the ability to understand what is happening around, the ability to communicate and, eventually, the ability to care for themselves. A team of scientists from London conducted a small study of 95 patients and determined that clusterin associated with early signs of the disease.
These studies are published in the journal Archives of General Psychiatry. "We found that the level of clusterin levels in people with Alzheimer rises above the norm for almost 10 years before the first clinical signs of the disease - said study leader Dr. Simon Lavston. - At these early stages Alzheimer's disease already present in the body, but still does not manifest itself. Now we need to develop a method of test, and then create a more effective analysis. I think that it will take three to five years. "
Industry News
Go back to the main page
No comments:
Post a Comment